FDA approves landmark pancreatic cancer drug that's shown to improve survival
The Food and Drug Administration granted approval Wednesday to the first-of-a-kind pill that uses a new approach to block a protein that fuels tumor growth in the vast majority of pancreatic cancer cases.
Open original source
No comments yet.